The effect of olmesartan on hypertensive cardiac remodeling
Not Applicable
- Conditions
- Hypertension accompanied with cardiovascular disease
- Registration Number
- JPRN-UMIN000013543
- Lead Sponsor
- ational Defense Medical College
- Brief Summary
This trial was terminated for the reason that enough number of patients could not be recruited.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
The patients whose (a) age <20 or >79, (b) prohibited to MRI, (c) expected high probability of the side-effect of ormethaltan, (d) ejection fraction <40%, (d) patients regarded as inappropriate for the study by doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method